Completed PHASE3 INTERVENTIONAL 3-arm NCT01296620

Ulimorelin Study of Efficacy and Safety (ULISES 008)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Ulimorelin Administered Post-Operatively to Accelerate Recovery of Gastrointestinal (GI) Motility in Subjects Who Have Undergone Partial Bowel Resection

Sponsor: Norgine

Conditions Gastrointestinal Dysmotility

Interventions 5% dextrose in water Ulimorelin Intravenously (IV) Ulimorelin Invtravenously (IV)

Updated 8 times since 2017 Last updated: Jul 25, 2012 Started: Feb 28, 2011 Primary completion: Mar 31, 2012 Completion: Mar 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01296620, this PHASE3 trial focuses on Gastrointestinal Dysmotility and remains completed. Sponsored by Norgine, it has been updated 8 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE3
Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Feb 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Norgine
Tranzyme, Inc.

Data source: Tranzyme, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bobigny, France , Boston, United States , Brno, Czechia , Clackamas, United States , Clichy Paris, France , Cluj-Napoca, Romania , El Paso, United States , Fargo, United States , Glendale, United States , Houston, United States and 30 more locations